Upper Urinary Tract
Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome)
Version of Record online: 1 MAR 2013
© 2013 BJU International
Volume 112, Issue 6, pages 813–819, October 2013
How to Cite
Hubosky, S. G., Boman, B. M., Charles, S., Bibbo, M. and Bagley, D. H. (2013), Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU International, 112: 813–819. doi: 10.1111/bju.12008
- Issue online: 13 SEP 2013
- Version of Record online: 1 MAR 2013
- 2Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001; 58: 174–178, , , , .
- 6A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. BJU Int 2012; doi: 10.1111/j.1464-410X.2012.11298.x [Epub ahead of print], , et al.
- 25Prevention of bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicenter, randomized clinical trial of a single postoperative intravesical dose of Mitomycin C (the ODMIT-C Trial). Eur Urol 2011; 60: 703–710, , , , .